MedCity News September 7, 2023
Medicare Advantage beneficiaries with a cancer diagnosis spend $3,996 on out-of-pocket costs and premiums annually, versus $6,091 for traditional Medicare beneficiaries with cancer, a new report found.
Medicare Advantage beneficiaries who have cancer or are cancer survivors spend more than $2,000 less on their healthcare compared to traditional Medicare beneficiaries with cancer, a new report found.
The report, published Thursday, was conducted by ATI Advisory and was commissioned by the Better Medicare Alliance, a research and lobby group for Medicare Advantage. The researchers relied on the 2019 Medicare Current Beneficiary Survey from the Centers for Medicare and Medicaid Services for the analysis.
They found that Medicare Advantage beneficiaries with a cancer diagnosis spend $3,996 on out-of-pocket costs and premiums annually,...
Today's Sponsors
Today's Sponsor